Lopinavir Completed Phase 1 Trials for Human Immunodeficiency Virus (HIV) Infections / Drug Drug Interaction (DDI) Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00307502Study to Determine the Pharmacokinetic Behavior of Antiretroviral Drugs in Patients Infected by HIV
NCT00665951Pharmacokinetic Study of Two Generic co-Formulations of Lopinavir/Ritonavir for HIV Infected Children (SURF)
NCT00135434Effect of HIV Protease Inhibitor Drugs on Glucose and Insulin Metabolism
NCT00038480Safety and Effectiveness of Lopinavir/Ritonavir in HIV Infected Infants
NCT00004580A Study of ABT-378/Ritonavir Combination in HIV-Infected Patients Who Have Taken Protease Inhibitors
NCT01227590Pharmacokinetic Interactions Between an Herbal Medicine (African Potato) and Antiretroviral Agents (Lopinavir/Ritonavir)
NCT00767117TMC125-TiDP2-C197: A Phase I Trial to Investigate the Pharmacokinetic Interaction Between Lopinavir/Ritonavir and TMC125 Both at Steady-state in Healthy Volunteers.